Clinical Trials Sponsored by Keryx Biopharmaceuticals

Total 719 results

Eikon Therapeutics
Seven and Eight Biopharmaceuticals Inc

Completed

BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors

Tumor, Solid

United States
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Worldwide Clinical Trials

Suspended

Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)

B-cell Non-Hodgkin's Lymphoma

United States
H. Lundbeck A/S
Alder Biopharmaceuticals, Inc.

Completed

Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman

Migraine

Australia
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

Phase 3 Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of TG103 Injection in Non-diabetic Overweight or Obesity

Overweight or Obesity

China
Zhongnan Hospital
Binhui Biopharmaceutical Co., Ltd.

Recruiting

First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer (CC-OV01)

Uterine Cervical Neoplasms

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Active, not recruiting

Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23

Healthy Volunteers

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Active, not recruiting

Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months

Meningitis, Meningococcal

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Active, not recruiting

Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months

Healthy Population

China
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Completed

Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above

Pneumonia, Pneumococcal

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia

Breast Cancer
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Completed

PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy

Lymphoma
Nationwide Children's Hospital
Asklepios Biopharmaceutical, Inc.

Completed

Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

United States
NGM Biopharmaceuticals, Inc
Merck Sharp & Dohme LLC

Active, not recruiting

Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Melanoma | Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Glioblastoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Endocervical Cancer

United States, Korea, Republic of, Taiwan
Eikon Therapeutics
Seven and Eight Biopharmaceuticals Inc

Active, not recruiting

BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab

Tumor, Solid

United States
Inovio Pharmaceuticals
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.

Terminated

Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 Disease

United States, Mexico, Colombia
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Peking University

Completed

Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors

HER2-positive Solid Tumors

China
Syneos Health
Shanghai Novamab Biopharmaceuticals Co. Ltd.

Terminated

First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036

Asthma

Australia
Raymond Chung
Eiger BioPharmaceuticals

Terminated

Pegylated Interferon Lambda Treatment for COVID-19

COVID-19 | COVID

United States
Samyang Biopharmaceuticals Corporation
Seoul National University Hospital

Completed

Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers

Healthy, Male

Korea, Republic of
University of California, San Diego
Navidea Biopharmaceuticals

Completed

Sentinel Lymph Node Mapping Post-Injection Site Pain

Breast Cancer

United States
Samyang Biopharmaceuticals Corporation
Chungnam National University Hospital

Completed

Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers

Healthy, Male
RegeneRx Biopharmaceuticals, Inc.
sigma-tau i.f.r. S.p.A.

Completed

Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers (SSVS)

Venous Stasis Ulcers

Italy, Poland
Fujian Cancer Hospital
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma (REVO)

Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma

China
Michael Camilleri, MD
NGM Biopharmaceuticals, Inc

Completed

Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)

Irritable Bowel Syndrome With Diarrhea | Bile Acid Malabsorption | Chronic Diarrhea | Functional Diarrhea | Bile Acid Diarrhea | Bile Acid Malabsorption Syndrome Type II

United States
Hangzhou Hanx Biopharmaceuticals, Ltd.
Wuhan Hanxiong Bioscience, Ltd.

Active, not recruiting

Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Genervon Biopharmaceuticals, LLC
Massachusetts General Hospital; Columbia University

Completed

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) (GALS)

Amyotrophic Lateral Sclerosis

United States
Nabi Biopharmaceuticals
National Institute on Drug Abuse (NIDA)

Completed

Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals

Smoking Cessation | Tobacco Use Cessation

Netherlands
Dragonboat Biopharmaceutical Company Limited
West China Hospital

Recruiting

An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor

Advanced Malignant Tumor

China
Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Completed

A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects

Obesity | Healthy Subjects | T2DM (Type 2 Diabetes Mellitus)

China
Shenzhen People's Hospital
Innovent Biopharmaceutical Co., Ltd.

Active, not recruiting

Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia

Efficacy and Safety | Heterozygous Familial Hypercholesterolemia | PCSK9

China
Hangzhou Hanx Biopharmaceuticals, Ltd.
Wuhan Hanxiong Bioscience, Ltd.

Completed

The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Dr. Tracey McLaughlin, MD
Eiger BioPharmaceuticals

Completed

Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia

Acquired Hyperinsulinemic Hypoglycemia

United States
National Institute on Drug Abuse (NIDA)
Nabi Biopharmaceuticals

Completed

Efficacy of NicVAX in Smokers Who Want to Quit Smoking

Smoking Cessation

United States
Nabi Biopharmaceuticals
National Institute on Drug Abuse (NIDA)

Completed

NicVAX/Placebo as an Aid for Smoking Cessation

Smoking | Smoking Cessation | Tobacco Cessation

United States
Eisai Inc.
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

Breast Cancer

United States, Japan
Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Recruiting

Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes

China
Dragonboat Biopharmaceutical Company Limited
West China Hospital

Recruiting

An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

Advanced Solid Tumors (Including GCTTS)

China
Beijing QL Biopharmaceutical Co.,Ltd
Beijing Hospital

Completed

A SAD Study of ZT002 Injection in Healthy Participants

Type 2 Diabetes Mellitus

China
Dragonboat Biopharmaceutical Company Limited
Shanghai East Hospital

Unknown

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Colorectal Cancer

China
Northwestern University
National Cancer Institute (NCI); Ipsen Biopharmaceuticals

Completed

Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditions

United States
Tritech Biopharmaceuticals Co., Ltd.
A2 Healthcare Taiwan Corporation

Unknown

A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients

Erectile Dysfunction

Taiwan
Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Completed

The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects

Non-alcoholic Steatohepatitis

Australia
Dragonboat Biopharmaceutical Company Limited
Shanghai East Hospital

Unknown

Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors

Advanced Tumors

China
Rise Biopharmaceuticals, Inc.
T-TOP Clinical Research Co., Ltd.

Recruiting

RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer

Pancreatic Cancer | Pancreatic Cancer Metastatic | Pancreatic Cancer Non-resectable

Taiwan
Connect Biopharma Australia Pty Ltd

Completed

A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects

Autoimmune Diseases

Australia, United States
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Tigermed Consulting Co., Ltd

Completed

Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma

HCC

China
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Shandong Cancer Hospital and Institute

Recruiting

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

Breast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Squamous Cell Cancer of Head and Neck

China
Day One Biopharmaceuticals, Inc.
Pacific Pediatric Neuro-Oncology Consortium

Recruiting

A Study to Evaluate DAY101 in Pediatric and Young Adult Patients With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors (FIREFLY-1)

Advanced Solid Tumor | Low-grade Glioma

United States, Israel, Korea, Republic of, Denmark, Singapore, Netherlands, Canada, Australia, Germany, Switzerland, United Kingdom
Connect Biopharma Australia Pty Ltd

Completed

Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults

Healthy Adult Subjects

Australia

Clinical Trials Sponsored by Keryx Biopharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations